Health Care Equipment & Services

AngioDynamics Q3 2026 results: $78.4 M sales, 8.9 % growth driven by Med Tech, EPS loss $0.19, raised 2026 guidance to $313–$316 M.

Humana Inc. (HUM) shares rose 3.3% in late March‑early April 2026, staying above its 52‑week low of $163.11 with a market cap of $21.44 billion. Explore the key factors driving the modest gains in this healthcare‑provider stock, including institutio…

Explore how CQ Pharmaceutical Holding Co Ltd can capitalize on China’s growing pharmaceutical innovation, with logistics expertise poised to boost revenue and investor returns.

CVS Health Corp sees a surge in institutional buying, steep options volume, and a price‑target cut amid a strategic pivot and FTC scrutiny—can the pharmacy giant navigate this turbulence?…

AirSculpt Technologies reports FY 2025 revenue down 15.5 % and net loss per share of $0.058, citing weaker demand for body‑contouring services.

AngioDynamics reports a record‑breaking Q3 with double‑digit Med Tech sales growth, a revised upbeat full‑year outlook, and a strong cash position, boosting investor confidence in its high‑growth vascular device pipeline.

VSee Health Inc.’s 2025 annual report reveals how its VSee Lab platform, low‑code telehealth solutions, and strategic partnerships drive growth amid fierce competition, demand swings, and market volatility.

Envoy Medical’s switch to Eisner Amper as auditor signals a strategic step to strengthen financial oversight amid going‑concern doubts, reflecting its push to stabilize and grow its hearing‑device business.

Short‑selling, earnings decline, and a downgrade from MDAX to SDAX are weighing on Carl Zeiss Meditec shares—investors eye analyst targets and TecDAX trends for the next move.

Milestone Scientific Inc. offers computer‑controlled anesthetic delivery systems for surgery, podiatry, dermatology, and orthopedics. Despite volatile NYSE American stock and a negative P/E, the company’s innovation and global reach suggest potentia…